Simon D Baines

发表

SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model

M. Wilcox, J. Freeman, R. Vickers, 2014, The Journal of antimicrobial chemotherapy.

In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.

M. Wilcox, J. Freeman, C. Chilton, 2014, The Journal of antimicrobial chemotherapy.

Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.

M. Wilcox, J. Freeman, S. Nicholson, 2013, The Journal of antimicrobial chemotherapy.

Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.

M. Wilcox, J. Freeman, Grace S Huscroft, 2011, The Journal of antimicrobial chemotherapy.

Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection

M. Wilcox, J. Freeman, S. Baines, 2009, Antimicrobial Agents and Chemotherapy.

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.

M. Wilcox, J. Freeman, S. Baines, 2008, The Journal of antimicrobial chemotherapy.

In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.

M. Wilcox, J. Freeman, R. O'Connor, 2008, The Journal of antimicrobial chemotherapy.

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.

M. Wilcox, J. Freeman, S. Baines, 2005, The Journal of antimicrobial chemotherapy.

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.

M. Wilcox, J. Freeman, C. Chilton, 2013, The Journal of antimicrobial chemotherapy.

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.

M. Wilcox, J. Freeman, S. Nicholson, 2014, The Journal of antimicrobial chemotherapy.

Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota

M. Wilcox, J. Freeman, S. Nicholson, 2014, PloS one.

Efficacy of Hospital Cleaning Agents and Germicides Against Epidemic Clostridium difficile Strains

M. Wilcox, R. Owens, K. Stephenson, 2007, Infection Control & Hospital Epidemiology.

Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production

R. Lewis, M. Wilcox, K. Stephenson, 2009, Journal of bacteriology.

In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile

M. Wilcox, P. Warn, J. Freeman, 2015, The Journal of antimicrobial chemotherapy.

Short-Term Genome Stability of Serial Clostridium difficile Ribotype 027 Isolates in an Experimental Gut Model and Recurrent Human Disease

T. Peto, D. Crook, A. Walker, 2013, PloS one.

The Changing Epidemiology of Clostridium difficile Infections

M. P. Bauer, E. Kuijper, M. Wilcox, 2010, Clinical Microbiology Reviews.

Should Test Methods for Disinfectants Use Vertebrate Viruses Dried on Carriers to Advance Virucidal Claims?

M. Wilcox, R. Owens, W. Fawley, 2008, Infection Control & Hospital Epidemiology.

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates

L. Villarreal-Treviño, A. Camacho-Ortíz, S. Baines, 2019, PLoS ONE.

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria

B. Wren, J. Swann, H. Kaur, 2018, PLoS pathogens.

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

M. Wilcox, S. Baines, Simon D Baines, 2015, Antibiotics.

Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes.

L. Villarreal-Treviño, A. Camacho-Ortíz, S. Baines, 2020 .

Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes.

L. Villarreal-Treviño, A. Camacho-Ortíz, S. Baines, 2020, Journal of microbiological methods.

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.

M. Wilcox, J. Freeman, S. Baines, 2009, The Journal of antimicrobial chemotherapy.

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.

M. Wilcox, J. Freeman, S. Baines, 2007, The Journal of antimicrobial chemotherapy.

Measurement of toxin production by Clostridium difficile

M. Wilcox, W. Fawley, J. Freeman, 2006, The Lancet.

Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.

M. Wilcox, J. Freeman, C. Chilton, 2013, The Journal of antimicrobial chemotherapy.

Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.

M. Wilcox, Joanne K. Hobbs, J. Freeman, 2011, The Journal of antimicrobial chemotherapy.

Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model

M. Wilcox, J. Freeman, S. Baines, 2008, Antimicrobial Agents and Chemotherapy.

Emergence of reduced susceptibility to metronidazole in Clostridium difficile.

E. Kuijper, M. Wilcox, P. Mastrantonio, 2008, The Journal of antimicrobial chemotherapy.

Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital.

M. Wilcox, W. Fawley, J. Freeman, 2005, The Journal of antimicrobial chemotherapy.

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico.

L. Villarreal-Treviño, R. Morfín-Otero, E. Garza-González, 2022, Enfermedades infecciosas y microbiologia clinica.

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico.

L. Villarreal-Treviño, A. Camacho-Ortíz, S. Baines, 2021, Enfermedades infecciosas y microbiologia clinica.